Ajanta Pharma Limited (AJANTPHARM.NS)

INR 2876.45

(-0.56%)

Market Cap (In INR)

359.3 Billion

Revenue (In INR)

42.08 Billion

Net Income (In INR)

8.16 Billion

Avg. Volume

217.39 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1850.25-3485.0
PE
-
EPS
-
Beta Value
0.104
ISIN
INE031B01049
CUSIP
Y0R6E1145
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Yogesh Mannalal Agrawal M.B.A
Employee Count
-
Website
https://www.ajantapharma.com
Ipo Date
2002-07-01
Details
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages. The company markets and serves various therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, pediatric, respiratory and general health products, dermatology, ophthalmology, and pain management areas. It also provides multivitamins, antibiotics, eye drops, cough syrups, etc. The company serves in India, Africa, rest of Asia, the United States, and internationally. It supplies its products to government bodies, including armed forces, government hospitals, canteens, stores department, etc. The company was founded in 1973 and is headquartered in Mumbai, India.